PPD and Evidera have joined MIT’s NEWDIGS initiative through which the CRO aims to scale sustainable, commercially viable tools to “drive more value faster.”
President Trump says he will sign the “big legislation” after the US House of Representatives passed the Right to Try Act – opponents of which warn lacks key patient protections.
Astellas will contract out an internal testing laboratory to Eurofins Scientific, marking the CRO’s entry into biopharmaceutical product testing in Japan.
The global health research network today has announced the availability of TriNetX Research, a suite of analytics solutions designed to leverage real-world data during observational and outcomes research.
Regulatory agencies are doubling down on compliance – and withholding funds – as the clinical research industry enters an era of accountability and transparency, say NIH officials.
LMC Manna Research has expanded its site network providing Phase I-IV clinical trial services to customers, such as Sanofi, which has launched a new program to reduce site burden.
Icon has announced a clinical research partnership with DuPage Medical Group, a Chicago, IL-based network with more than 700 physicians across more than 100 locations.
Researchers at John Hopkins Bloomberg School of Public Health cite lack of staff as one of the main causes of many academic institutions being slow to adhere to new clinical trial reporting requirements.
The Chinese contract research and development company WuXi AppTec has raised more than $353m in its initial public offering of common stock on the Shanghai Stock Exchange.
Evotec has entered into a strategic collaboration to accelerate Carna Biosciences’s program CB-1763, which is being developed for the treatment of blood cancer.
Novartis’ recently launched FocalView app will be used in a new study to remotely collect electronic device reported outcome measurements (eDROs) from 150,000 users.
monARC Bionetworks has announced an integration with Roivant’s drug development platform, as part of which the healthcare technology provider will receive a strategic investment.
The company, which has partnerships to support clinical trials recruitment, has received an unsolicited acquisition offer from Elliott Management – skyrocketing the EHR provider’s stock.
Significant regulatory changes by the Chinese government will accelerate drug development timelines and positively affect sponsors’ bottom line, says CRO.
The UK government has provided the “strongest possible reassurance” that it will implement the incoming European Union Clinical Trial Regulation, whatever happens in the Brexit negotiations.
The global contract research organization (CRO) market is forecasted to grow 12% year-on-year through 2021 – led by IQVIA with 12.4% of the market share.
Responding to the need of ensuring information integrity, Scientist.com has launched DataSmart – which applies blockchain technology to protect data throughout the drug development process.
PSI CRO has opened a new office in the California Bay Area to support continued growth organically – which, according to the company, is what drives its success.
Novartis has launched FocalView, a new app that aims to allow researchers to track ophthalmic disease progression by collecting real-time data from patients.
UK-headquartered RxCelerate has acquired the specialist bioanalytical contract research organization Total Scientific – increasing its staff to 37 following its expansion stateside in November 2017.
Enteris BioPharma has completed recruitment and initial dosing of all subjects for an additional treatment arm of its Phase IIa clinical trial, which is being conducted by Syneos.
The R&D facility will help clients advance pharmaceutical ingredients from preclinical to commercial stage, says the contract development and manufacturing organisation.
By Doug Peddicord, PhD, executive director, Association of Clinical Research Organizations
The CRO market is expected to reach $45bn by 2022, with outsourcing work having increased by 40% in the past decade — yet the industry remains largely elusive, until now.
Following one of the worst flu seasons in years, several companies are working to develop a universal vaccine, with the first clinical trials in humans now underway.
A continued need for specialized services and expertise will keep smaller firms in business – though many have forecasted the “death of small- to mid-sized CROs” as the industry continues to consolidate, say experts.
Acurian and Synexus have introduced a new clinical trial enrollment solution for patients with nonalcoholic fatty liver disease, which is often underdiagnosed.
Glenmark Pharmaceuticals has suspended a Phase II clinical trial at a site in India following media reports that villagers were allegedly “deceived” into participating.
The contract research organization (CRO) Synteract today announced the creation of “therapeutic centers of development” as it looks to deepen its footprint in the mid-size CRO market space.
The industry’s current research model is failing patients who live in a mobile world and will not sustain if clinical trials continue to take years to recruit, says industry expert.
Tufts Medical Center has joined TriNetX’s research network to improve its clinical trial process, further expanding the company’s reach as it looks to grow internationally and introduce new offerings in 2018.
The acquisition of Analytica Laser adds real-world effectiveness prediction and value assessment to Certara's service portfolio – as it aims to “tackle trial to real-world value translation,” says exec.
PharmaCyte’s live-cell encapsulation technology could change the way solid tumor cancers are treated, says CEO, as the biotech moves forward with CRO selection ahead of its Ph IIb clinical trial – which will is expected to cost between $15 and $17m.
To bridge the gap between clinical research and health care, the industry must connect with marginalized practitioners and patients – and create greater incentives for collaboration.
LabCorp is investing $30m in a new operations center at the former GSK campus in Research Triangle Park with support from a job development grant worth more than $8m.
The mobile health platform from Oracle Health Sciences enables clinical study teams to collect remote patient data from sensors, wearables, and apps – and promises to deliver “a new level of patient centricity.”
Parexel and Meiji Pharmaceutical University have announced a new academic program to develop the biopharmaceutical workforce in Japan and meet the industry’s demand for talent in clinical research.
Pfizer will recruit patients with rare diseases and identify clinical trial sites with support from the TriNetX global health research network, which is becoming "the defacto platform" for research, says CEO.
Frontage Laboratories has acquired Concord Biosciences, taking a “significant step” towards the company’s goal of building a global organization, says CEO.
Patient recruitment is underway for a genomics-based pilot program to study opioid abuse and addiction – a first step in extending precision medicine into clinical practice for addiction, says CRO Genemarkers.
